Public Calendar: March 7-13 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 03/09/2021
Location: Virtual
Subject: Trends in COVID-19 Therapeutic Clinical Trials
FDA Participant/Group: DAYLE CRISTINZIO; RICHARDAE ARAOJO;
Non FDA Participant/Group: Several members of the Association of Clinical Research Organizations Board of Directors and staff

Event Date: 03/09/2021
Location: Virtual
Subject: Emergency Use Authorizations for COVID-19 Therapeutics
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from Infectious Diseases Society of America and the HIV Medicine Assocation

Event Date: 03/10/2021
Location: Virtual
Subject: Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media and other registered guests

Event Date: 03/10/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 03/10/2021
Location: Virtual
Subject: Variant Testing Data
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic and Vaccines (ACTIV)

Event Date: 03/11/2021
Location: Virtual
Subject: Priorities for 2021 and FDA Resource Needs
FDA Participant/Group: MELISSA ROBB; DAYLE CRISTINZIO; JULIA TIERNEY; STEPHANIE SOCGFACK;
Non FDA Participant/Group: Several members from The Alliance for a Stronger FDA

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 03/09/2021
Location: Virtual
Subject: Listening Session with the Infectious Diseases Society of America and the HIV Medicine Association
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry Stakeholders

Event Date: 03/11/2021
Location: Virtual
Subject: MITRE Grand Challenges Power Hour: Leveraging Insights from COVID-19 to Accelerate Health Care Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry Stakeholders

Event Date: 03/12/2021
Location: Virtual
Subject: Medical Device Innovation Consortium (MDIC) / FDA Quarterly Touch Base
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry Stakeholders

Official Name: Erika Anderson, Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 03/10/2021
Location: Virtual
Subject: Consumer Food Safety Education Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Executives and staff from across the food industry, academia, state and federal government

Event Date: 03/11/2021
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, scientific and technical staff from industry

Event Date: 03/12/2021
Location: Virtual
Subject: Food Safety Culture
FDA Participant/Group: Several FDA Staff
Non FDA Participant/Group: Several executives from food retailers and Stop Foodborne Illness

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/08/2021
Location: Virtual
Subject: Update on COVID-19 Vaccines and Emergency Use Authorization
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Research!America Alliance

Event Date: 03/09/2021
Location: Virtual
Subject: 7th International Conference on Accelerating Biopharmaceutical Development; Keynote: Accelerating the Pace of Vaccine Development During a Pandemic – and After
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 03/11/2021
Location: Virtual
Subject: America's Blood Centers Annual Meeting; Speaker: FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

Event Date: 03/10/2021
Location: Virtual
Subject: List of Deemed New Tobacco Products Covered by the Continued Compliance Policy
FDA Participant/Group: ANN SIMONEAU; MATTHEW HOLMAN; MITCHELL ZELLER;
Non FDA Participant/Group: Several staff from Coalition of Manufacturers of Smoking Alternatives

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 03/12/2021
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; ANTONIA MONIQUE SENNETT; JEANETTE MURPHY; GREGORY TYSON;
Non FDA Participant/Group: Representatives from United States Animal Health Association (USAHA)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event